Noroviruses as a cause of diarrhea in immunocompromised pediatric hematopoietic stem cell and solid organ transplant recipients

American Journal of Transplantation

Volumn 15, Issue 7, 2015, Pages 1874-1881

  Ye, X ^a   Van, J N ^a   Munoz, F M ^a,b   Revell, P A ^a,b   Kozinetz, C A ^c   Krance, R A ^a,b   Atmar, R L ^a   Estes, M K ^a   Koo, H L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

clinical research practice; infection and infectious agents; infectious disease; intestinal disease: infectious; pediatrics; viral

Indexed keywords

CREATININE; VIRUS RNA;

ARTICLE; CHILD; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DEFECATION HABIT; DIARRHEA; DISEASE DURATION; EVALUATION STUDY; FECES ANALYSIS; FEMALE; GASTROINTESTINAL TRACT EXAMINATION; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NOROVIRUS; NOROVIRUS INFECTION; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PNEUMATOSIS INTESTINALIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID ORGAN TRANSPLANTATION; VIRUS DETECTION; VIRUS LOAD; WEIGHT REDUCTION; CALICIVIRUS INFECTION; CHEMISTRY; CLINICAL TRIAL; FECES; FOLLOW UP; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROGNOSIS; RISK FACTOR; TEXAS; VIROLOGY;

CALICIVIRIDAE INFECTIONS; CHILD; DIARRHEA; FECES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; NOROVIRUS; ORGAN TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; TEXAS; TRANSPLANT RECIPIENTS;

EID: 84931563377     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13227     Document Type: Article

References (40)

1. Hall AJ, Lopman BA, Payne DC, et al., Norovirus disease in the United States. Emerg Infect Dis 2013; 19: 1198-1205.
2. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA,. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 2012; 55: 216-223.
3. Payne DC, Vinje J, Szilagyi PG, et al., Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013; 368: 1121-1130.
4. Bull RA, Tu ET, McIver CJ, Rawlinson WD, White PA,. Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis. J Clin Microbiol 2006; 44: 327-333.
5. Koo HL, Ajami NJ, Jiang ZD, et al., Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol 2010; 48: 1673-1676.
6. Ginsburg PM, Thuluvath PJ,. Diarrhea in liver transplant recipients: Etiology and management. Liver Transpl 2005; 11: 881-890.
7. Cox GJ, Matsui SM, Lo RS, et al., Etiology and outcome of diarrhea after marrow transplantation: A prospective study. Gastroenterology 1994; 107: 1398-1407.
8. van Kraaij MG, Dekker AW, Verdonck LF, et al., Infectious gastro-enteritis: An uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant 2000; 26: 299-303.
9. Robles JD, Cheuk DK, Ha SY, Chiang AK, Chan GC,. Norovirus infection in pediatric hematopoietic stem cell transplantation recipients: Incidence, risk factors, and outcome. Biol Blood Marrow Transplant 2012; 18: 1883-1889.
10. Yolken RH, Bishop CA, Townsend TR, et al., Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med 1982; 306: 1010-1012.
11. Kamboj M, Mihu CN, Sepkowitz K, Kernan NA, Papanicolaou GA,. Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield. Transpl Infect Dis 2007; 9: 265-269.
12. Roddie C, Paul JP, Benjamin R, et al., Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: A previously unrecognized cause of morbidity. Clin Infect Dis 2009; 49: 1061-1068.
13. Ebdrup L, Bottiger B, Molgaard H, Laursen AL,. Devastating diarrhoea in a heart-transplanted patient. J Clin Virol 2011; 50: 263-265.
14. Roos-Weil D, Ambert-Balay K, Lanternier F, et al., Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation 2011; 92: 61-69.
15. Schwartz S, Vergoulidou M, Schreier E, et al., Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood 2011; 117: 5850-5856.
16. Koo HL, Neill FH, Estes MK, et al., Noroviruses: The most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination. J Pediatric Infect Dis Soc 2013; 2: 57-60.
17. Saito M, Goel-Apaza S, Espetia S, et al., Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis 2014; 58: 483-491.
18. World Health Organization. Diarrhoeal disease fact sheet. [cited 2014 July 29]. Available from: http://www.who.int/mediacentre/factsheets/fs330/en/
19. Koo HL, Ajami NJ, Jiang ZD, Atmar RL, DuPont HL,. Norovirus infection as a cause of sporadic healthcare-associated diarrhoea. J Hosp Infect 2009; 72: 185-187.
20. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinje J,. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg Infect Dis 2011; 17: 1389-1395.
21. Kroneman A, Vennema H, Deforche K, et al., An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol 2011; 51: 121-125.
22. Luna RA, Boyanton BL, Jr., Mehta S, et al., Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital. J Clin Microbiol 2011; 49: 851-857.
23. Jiang ZD, Lowe B, Verenkar MP, et al., Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 2002; 185: 497-502.
24. Kageyama T, Shinohara M, Uchida K, et al., Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to Norovirus in Japan. J Clin Microbiol 2004; 42: 2988-2995.
25. Tomblyn M, Chiller T, Einsele H, et al., Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective. Biol Blood Marrow Transplant 2009; 15: 1143-1238.
26. Florescu DF, Hill LA, McCartan MA, Grant W,. Two cases of Norwalk virus enteritis following small bowel transplantation treated with oral human serum immunoglobulin. Pediatr Transplant 2008; 12: 372-375.
27. Kim MJ, Kim YJ, Lee JH, et al., Norovirus: A possible cause of pneumatosis intestinalis. J Pediatr Gastroenterol Nutr 2011; 52: 314-318.
28. Bok K, Green KY,. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012; 367: 2126-2132.
29. Ferrara JL, Deeg HJ,. Graft-versus-host disease. N Engl J Med 1991; 324: 667-674.
30. Kaufman SS, Chatterjee NK, Fuschino ME, et al., Characteristics of human calicivirus enteritis in intestinal transplant recipients. J Pediatr Gastroenterol Nutr 2005; 40: 328-333.
31. Krones E, Hogenauer C,. Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am 2012; 41: 677-701.
32. Graham DY, Jiang X, Tanaka T, Opekun AR, Madore HP, Estes MK,. Norwalk virus infection of volunteers: New insights based on improved assays. J Infect Dis 1994; 170: 34-43.
33. Phillips G, Lopman B, Tam CC, Iturriza-Gomara M, Brown D, Gray J,. Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect Dis 2009; 9: 63.
34. Atmar RL, Opekun AR, Gilger MA, et al., Norwalk virus shedding after experimental human infection. Emerg Infect Dis 2008; 14: 1553-1557.
35. Ajami N, Koo H, Darkoh C, et al., Characterization of norovirus-associated traveler's diarrhea. Clin Infect Dis 2010; 51: 123-130.
36. Boon D, Mahar JE, Abente EJ, et al., Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J Virol 2011; 85: 8656-8666.
37. Saif MA, Bonney DK, Bigger B, et al., Chronic norovirus infection in pediatric hematopoietic stem cell transplant recipients: A cause of prolonged intestinal failure requiring intensive nutritional support. Pediatr Transplant 2011; 15: 505-509.
38. Florescu DF, Hermsen ED, Kwon JY, et al., Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients? Pediatr Transplant 2011; 15: 718-721.
39. Chen Z, Sosnovtsev SV, Bok K, et al., Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis. J Virol 2013; 87: 9547-9557.
40. Atmar RL, Bernstein DI, Harro CD, et al., Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011; 365: 2178-2187.